Preterm health: time to bridge the evidence gap

Affiliations

¹ Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK. Electronic address: rebeccah.slater@paediatrics.ox.ac.uk.
² Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
³ Paediatric Medicines Office, Scientific Evidence Generation Department, European Medicines Agency, Amsterdam, Netherlands.
⁴ Department of Paediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, University of Basel, Basel, Switzerland; Division of Clinical Pharmacology, Children's National Hospital, Washington, DC, USA; Intensive Care and Department of Pediatric Surgery, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, Netherlands.

Rebeccah Slater et al. Lancet. 2020.

. 2020 Sep 26;396(10255):872-873.

doi: 10.1016/S0140-6736(20)31977-2.

¹ Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK. Electronic address: rebeccah.slater@paediatrics.ox.ac.uk.
² Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
³ Paediatric Medicines Office, Scientific Evidence Generation Department, European Medicines Agency, Amsterdam, Netherlands.
⁴ Department of Paediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, University of Basel, Basel, Switzerland; Division of Clinical Pharmacology, Children's National Hospital, Washington, DC, USA; Intensive Care and Department of Pediatric Surgery, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, Netherlands.

No abstract available

Publication types